Skip to main content
Clinical Trials/NCT05840744
NCT05840744
Not yet recruiting
Not Applicable

Evaluation of Risk Factors, Clinical Pattern and Outcome of Thrombosis in Children

Sohag University1 site in 1 country30 target enrollmentMay 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thrombosis in Children
Sponsor
Sohag University
Enrollment
30
Locations
1
Primary Endpoint
occurance of in-hospital mortality
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

Pediatric thrombosis is multifactorial, and usually risk factors either congenital or acquired are present.

Patient may has one risk factor or more such as sepsis, cancers, congenital heart disease, post surgery , central venous catheter insertion, nephrotic syndrome, systemic lupus erythromatosis and inflammatory bowel disease.

If there's no obvious risk factor for thrombosis, hereditary thrombophilia is suspected which results when an inherited factor, such as antithrombin , protein C or protein S deficiency.

Detailed Description

Thrombosis is the formation of a blood clot (partial or complete blockage) within blood vessels, whether venous or arterial, limiting the natural flow of blood and resulting in clinical sequela. Incidence of childhood thrombosis is 0.07-0.14/10,000 in the general population. This incidence has been reported to be 5.3/10,000 in children presenting to hospital, 0.51/10,000 in all newborns and 0.24/10,000 in children in neonatal intensive care units . Pediatric thrombosis is multifactorial, and usually risk factors either congenital or acquired are present. . Patient may has one risk factor or more such as sepsis, cancers, congenital heart disease, post surgery , central venous catheter insertion, nephrotic syndrome, systemic lupus erythromatosis and inflammatory bowel disease. If there's no obvious risk factor for thrombosis, hereditary thrombophilia is suspected which results when an inherited factor, such as antithrombin , protein C or protein S deficiency. There are three changes described by Virchow in 1856 are involved in the formation of thrombosis: 1. Changes in blood flow (rheology, stasis) 2. Changes in the vascular wall 3. Changes in the blood levels of coagulation factors The diagnosis of thrombosis is made more frequently and more easily in children due to noninvasive diagnos-tic methods \[Doppler and ultrasonography (US), echo-cardiography, computed tomography (CT) and magnet-ic resonance imaging (MRI)\]. The morbidity and mortality rates are high, although it occurs more rarely compared with adult thrombosis and does not develop in the absence of a triggering factor; the rate of mortality related with direct venous thromboembolism is 2.2%, the frequency of post-thrombotic syndrome is 12.4%, and the recurrence rate for thrombosis is 8.1%.

Registry
clinicaltrials.gov
Start Date
May 1, 2023
End Date
April 13, 2024
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Haidy Abdelazim Youssif

Resident of pediatric and neonatology department, Sohag University Hospitals

Sohag University

Eligibility Criteria

Inclusion Criteria

  • All children age from one day to 18 yrs presented with any vascular thrombosis decomented by clinical picture and venous doppler study or radiological study.

Exclusion Criteria

  • • Persons above 18 years old.

Outcomes

Primary Outcomes

occurance of in-hospital mortality

Time Frame: 12 months

detection the mortality occurance in patients with thrombosis within admission in hospital

Occurance of neurological deficit

Time Frame: 12 months

occurance of neurological deficit at the end of hospital admission and before discharge.

Study Sites (1)

Loading locations...

Similar Trials